Calprotectin levels in necrotizing enterocolitis: a systematic review of the literature

Inflammation Research

Volumn 65, Issue 11, 2016, Pages 847-852

  Pergialiotis, Vasilios ^a   Konstantopoulos, Panagiotis ^a   Karampetsou, Nikoleta ^a   Koutaki, Diamanto ^a   Gkioka, Eleana ^a   Perrea, Despina N ^a   Papantoniou, Nikolaos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Fecal calprotectin; NEC; Necrotizing enterocolitis; S100A8; S100A9

Indexed keywords

ANTIBIOTIC AGENT; CALGRANULIN; INOTROPIC AGENT; BIOLOGICAL MARKER;

BIBLIOGRAPHIC DATABASE; CLINICAL EVALUATION; COCHRANE LIBRARY; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES; FECES ANALYSIS; HUMAN; MEDLINE; NECROTIZING ENTEROCOLITIS; NEWBORN SCREENING; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PREMATURITY; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; REVIEW; SCOPUS; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; CHEMISTRY; METABOLISM;

BIOMARKERS; ENTEROCOLITIS, NECROTIZING; FECES; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX;

EID: 84975255389     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-016-0963-9     Document Type: Review

References (36)

1. Fitzgibbons SC, Ching Y, Yu D, Carpenter J, Kenny M, Weldon C, et al. Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg. 2009;44:1072–5 (discussion 1075–6).
2. Thompson AM, Bizzarro MJ. Necrotizing enterocolitis in newborns: pathogenesis, prevention and management. Drugs. 2008;68:1227–38.
3. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187:1–7.
4. Moss RL, Dimmitt RA, Barnhart DC, Sylvester KG, Brown RL, Powell DM, et al. Laparotomy versus peritoneal drainage for necrotizing enterocolitis and perforation. N Engl J Med. 2006;354:2225–34.
5. Young C, Sharma R, Handfield M, Mai V, Neu J. Biomarkers for infants at risk for necrotizing enterocolitis: clues to prevention? Pediatr Res. 2009;65:91R–7R.
6. Oh S, Young C, Gravenstein N, Islam S, Neu J. Monitoring technologies in the neonatal intensive care unit: implications for the detection of necrotizing enterocolitis. J Perinatol Off J Calif Perinat Assoc. 2010;30:701–8.
7. Striz I, Trebichavsky I. Calprotectin—a pleiotropic molecule in acute and chronic inflammation. Physiol Res Acad Scientiarum Bohemoslov. 2004;53:245–53.
8. Thuijls G, Derikx JP, van Wijck K, Zimmermann LJ, Degraeuwe PL, Mulder TL, et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg. 2010;251:1174–80.
9. Burri E, Beglinger C. Faecal calprotectin—a useful tool in the management of inflammatory bowel disease. Swiss Med Wkly. 2012;142:w13557.
10. Konikoff MR, Denson LA. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:524–34.
11. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1–34.
12. Wells GA, Shea B, O`Connel D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. 2011. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 27 Nov 2015.
13. Carroll D, Corfield A, Spicer R, Cairns P. Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis. Lancet. 2003;361:310–1.
14. Altamimi EM, Murthy P, Urbaniak C, Grey VL, Denou E, Issenman R. Prospective non-randomized diagnostic pilot study using fecal calprotectin for diagnosing necrotizing enterocolitis (NEC) in very low birth weight infants. Gastroenterology. 2011;140:S-685–6.
15. Aydemir G, Cekmez F, Tanju IA, Canpolat FE, Genc FA, Yildirim S, et al. Increased fecal calprotectin in preterm infants with necrotizing enterocolitis. Clin Lab. 2012;58:841–4.
16. Aydemir O, Aydemir C, Sarikabadayi YU, Emre Canpolat F, Erdeve O, Biyikli Z, et al. Fecal calprotectin levels are increased in infants with necrotizing enterocolitis. J Matern Fetal Neonatal Med. 2012;25:2237–41.
17. Reisinger KW, Van der Zee DC, Brouwers HA, Kramer BW, van Heurn LW, Buurman WA, et al. Noninvasive measurement of fecal calprotectin and serum amyloid A combined with intestinal fatty acid-binding protein in necrotizing enterocolitis. J Pediatr Surg. 2012;47:1640–5.
18. Terrin G, Passariello A, De Curtis M, Paludetto R, Berni Canani v. S100 A8/A9 protein as a marker for early diagnosis of necrotising enterocolitis in neonates. Arch Dis Child. 2012;97:1102.
19. Albanna EA, Ahmed HS, Awad HA. Stool calprotectin in necrotizing enterocolitis. Journal Clin Neonatol. 2014;3:16–9.
20. Selimoglu MA, Temel I, Yildirim C, Ozyaln F, Aktas M, Karabiber H. The role of fecal calprotectin and lactoferrin in the diagnosis of necrotizing enterocolitis. Pediatr Crit Care Med. 2012;13:452–4.
21. Yoon JM, Park JY, Ko KO, Lim JW, Cheon EJ, Kim HJ. Fecal calprotectin concentration in neonatal necrotizing enterocolitis. Korean J Pediatr. 2014;57:351–6.
22. Fagerberg UL, Loof L, Merzoug RD, Hansson LO, Finkel Y. Fecal calprotectin levels in healthy children studied with an improved assay. J Pediatr Gastroenterol Nutr. 2003;37:468–72.
23. Bin-Nun A, Booms C, Sabag N, Mevorach R, Algur N, Hammerman C. Rapid fecal calprotectin (FC) analysis: point of care testing for diagnosing early necrotizing enterocolitis. Am J Perinatol. 2015;32:337–42.
24. Shenoy M, Shenoy KT, Roseth A, Geir L, Keshavamurthy SR. Diagnostic utility of fecal calprotectin as a biomarker of gut inflammation in neonates to predict necrotizing enterocolitis: a prospective study. Indian J Child Health. 2014;1:99–104.
25. Avula S, Nantais-Smith L, Monga R, Lockwood L, Lansing E, Kadrofske M. Stool biomarkers to diagnose necrotizing enterocolitis in preterm infants: a pilot case-control study. AAP National Conference and Exhibition October 23–27, 2015.
26. Shenoy MT, Shenoy KT, Roseth A, Geir L, Keshavamurthy SR. Diagnostic utility of fecal calprotectin as a biomarker of gut inflammation in neonates to predict necrotizing enterocolitis: a prospective study. Indian J Child Health. 2014;1:99–104.
27. Tang WH, Guan MC, Jiang XJ, Teng CZ, Wang HT. The clinical significance of fecal calprotectin on premature infant with necrotizing enterocolitis. Chin J Health Lab Technol. 2013;4:23–8.
28. Altamimi EM, Murthy P, Urbaniak C, Grey VL, Denou E, Issenman R. Prospective non-randomized diagnostic pilot study using fecal calprotectin for diagnosing necrotizing enterocolitis (NEC) in very low birth weight infants. Gastroenterology. 2011;140:S-685–6.
29. Avula S, LN-S, Monga R, Lockwood L, Kadrofske M. Stool biomarkers to diagnose necrotizing enterocolitis in preterm infants: a pilot case-control study. American Academy of Pediatrics. Washington, DC; 24–27 Oct 2015.
30. Elgin TG, Kern SL, McElroy SJ. Development of the neonatal intestinal microbiome and its association with necrotizing enterocolitis. Clin Ther. 2016;38:706–15.
31. Erbayrak M, Turkay C, Eraslan E, Cetinkaya H, Kasapoglu B, Bektas M. The role of fecal calprotectin in investigating inflammatory bowel diseases. Clinics (Sao Paulo, Brazil). 2009;64:421–5.
32. Isaksen B, Fagerhol MK. Calprotectin inhibits matrix metalloproteinases by sequestration of zinc. Mol Pathol MP. 2001;54:289–92.
33. Polycarpou E, Zachaki S, Papaevangelou V, Tsolia M, Kyriacou A, Kostalos C, et al. Oral l-arginine supplementation and faecal calprotectin levels in very low birth weight neonates. J Perinatol Off J Calif Perinat Assoc. 2013;33:141–6.
34. Laforgia N, Baldassarre ME, Pontrelli G, Indrio F, Altomare MA, Di Bitonto G, et al. Calprotectin levels in meconium. Acta Paediatr (Oslo, Norway 1992). 2003;92:463–6.
35. Campeotto F, Baldassarre M, Butel MJ, Viallon V, Nganzali F, Soulaines P, et al. Fecal calprotectin: cutoff values for identifying intestinal distress in preterm infants. J Pediatr Gastroenterol Nutr. 2009;48:507–10.
36. Yang Q, Smith PB, Goldberg RN, Cotten CM. Dynamic change of fecal calprotectin in very low birth weight infants during the first month of life. Neonatology. 2008;94:267–71.